| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ZEB1_0007400 | Exon-Intron | chr10:31644076-31676195 | chr10:31355147-31387266 | 250 nt | 0.3480 |
| hsa_ZEB1_0007500 | Exon-Intron | chr10:31644076-31676727 | chr10:31355147-31387798 | 250 nt | 0.3040 |
| hsa_ZEB1_0011600 | Exon-Exon | chr10:31661947-31663893 | chr10:31373018-31374964 | 1947 nt | 0.3082 |
| hsa_ZEB1_0011700 | Exon-Exon | chr10:31661947-31676195 | chr10:31373018-31387266 | 250 nt | 0.3400 |
| hsa_ZEB1_0011800 | Exon-Exon | chr10:31661947-31676727 | chr10:31373018-31387798 | 250 nt | 0.2960 |
| hsa_ZEB1_0012100 | Intron-Exon-Intron | chr10:31661947-31678624 | chr10:31373018-31389695 | 250 nt | 0.3000 |
| hsa_ZEB1_0012400 | Intron-Exon-Intron | chr10:31661947-31709678 | chr10:31373018-31420749 | 250 nt | 0.3120 |
| hsa_ZEB1_0012600 | Exon-Exon | chr10:31661947-31750166 | chr10:31373018-31461237 | 250 nt | 0.3640 |
| hsa_ZEB1_0012900 | Exon-Exon | chr10:31661947-31791437 | chr10:31373018-31502509 | 250 nt | 0.3520 |
| hsa_ZEB1_0013700 | Exon-Exon | chr10:31662051-31676195 | chr10:31373122-31387266 | 250 nt | 0.3240 |
A study in humans identified the circZEB1 as a potential biomarker for immune-mediated demyelinating disease, where its levels in cerebrospinal fluid exosomes were specifically validated [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in humans demonstrated that circZEB1 was upregulated in left atrial appendages of patients with atrial fibrillation [Tian et al. DOI:10.3390/molecules26041155].